The IL-4 receptor: Signaling mechanisms and biologic functions

Annual Review of Immunology

Volumn 17, Issue , 1999, Pages 701-738

  Nelms, Keats ^a,c   Keegan, Achsah D ^b   Zamorano, José ^b   Ryan, John J ^a,d   Paul, William E ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b HOLLAND LABORATORY   (United States)

^c MONSANTO COMPANY   (United States)

^d VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

FRIP; Interleukin 4; Interleukin 4 receptor; IRS 1 2; Janus kinases; Phosphatase; Stat 6

Indexed keywords

INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN TYROSINE PHOSPHATASE; STAT6 PROTEIN;

ALPHA CHAIN; ANIMAL CELL; APOPTOSIS; CELL DIFFERENTIATION; CELL GROWTH; ENZYME REGULATION; GENE ACTIVATION; IMMUNE RESPONSE; IMMUNOMODULATION; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; RECEPTOR BINDING; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; REVIEW; SIGNAL TRANSDUCTION;

AMINO ACID SEQUENCE; ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; HUMANS; INTERLEUKIN-4; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MICE; MICE, KNOCKOUT; MITOGEN-ACTIVATED PROTEIN KINASES; MOLECULAR SEQUENCE DATA; PHOSPHOPROTEINS; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, INTERLEUKIN-4; SIGNAL TRANSDUCTION; STAT6 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0033010373     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.17.1.701     Document Type: Review

References (183)

1. Seder RA, Paul WE. 1994. Acquisition of lymphokine-producing phenotype by CD4+ T-cells, Annu. Rev. Immunol. 12:635-73
2. Yoshimoto T, Paul WE. 1994. CD4pos, NK1.1pos T-cells promptly produce Interleukin-4 in response to in-vivo challenge with anti-CD3 J. Exp. Med. 179: 1285-95
3. Chen HJ, Paul WE. 1997. Cultured NK1.1(+)CD4(+) T cells produce large amounts of IL-4 and IFN-gamma upon activation by anti-CD3 or CD1. J. Immunol. 159:2240-49
4. Ferrick DA, Schrenzel MD, Mulvania T, Hsich B, Ferlin WG, Lepper H. 1995. Differential production of interferon-gamma and interleukin-4 in response to TH1-stimulating and TH2-stimulating pathogens by gamma-delta T-cells in vivo. Nature 373:255-57
5. Zuany-Amorim C, Ruffie C, Haile S, Vargaftig BB, Pereira P, Pretolani M. 1998. Requirement for gamma delta T cells in allergic airway inflammation. Science 280:1265-67
6. Dubucquoi S, Desreumaux P, Janin A, Klein O, Goldman M, Tavernier J, Capron M, Capron A. 1994. lnterleukin-5 secretion by cosinophils-association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179:703-8
7. Seder RA, Paul WE, Davis MM, De ST, Groth BF. 1992. The presence of interleukin-4 during in vitro priming determines the lymphokine-producing potential of CD4 + T-cells from T-cell receptor transgenic mice. J. Exp. Med. 176: 1091-98
8. Hsich CS, Heimberger AB, Gold JS, O'Garra A, Murphy KM. 1992. Differential regulation of T-helper phenotype development by interleukin-4 and interleukin-10 in an alpha-beta-T-cell-receptor transgenic system, Proc. Natl. Acad. Sci. USA 89:6065-69
9. Gascan H, Gauchat JF, Roncarolo MG, Yssel H, Spits H, de Vries JE. 1991. Human B cell clones can be induced to proliferate and to switch to IgE and IgG4 synthesis by interleukin 4 and a signal provided by activated CD4+ T cell clones. J. Exp. Med. 173:747-50
10. Coffman RL, Ohara J, Bond MW, Carty J, Zlotnik A, Paul WE. 1986. B cell stimulatory factor-1 enhances the IgE response of lipopolysaccharide-activated B cells. J. Immunol. 136:4538-41
11. Vitetta ES, Ohara J, Myers CD, Layton JE, Krammer PH, Paul WE. 1985. Serological, biochemical, and functional identity of B cell-stimulatory factor 1 and B cell differentiation factor for IgG1. J. Exp. Med. 162:1726-31
12. Kuhn R, Rajewsky K, Muller W. 1991. Generation and analysis of interleukin-4 deficient mice. Science 254:707-10
13. Noben-Trauth N, Shultz LD, Brombacher F, Urban JF Jr, Gu H, Paul WE. 1997. An interleukin 4 (IL-4)-independent pathway for CD4+ T cell IL-4 production is revealed in IL-4 receptor-deficient mice. Proc. Natl. Acad. Sci. USA 94:10838-43
14. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, et al. 1996. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat-6 gene. Nature 380:630-33
15. Kaplan MH, Schindler U, Smiley ST, Grusby MJ. 1996. Stat-6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313-19
16. Akira S, Kishimoto T. 1997. NF-IL6 and NF-kappa B in cytokine gene regulation. Adv. Immunol. 65:1-46
17. O'Garra A, Steinman L, Gijbels K. 1997. CD4(+) T-cell subsets in autoimmunity. Curr. Opin. Immunol. 9:872-83
18. Noelle R, Kramme RP, Ohara J, Uhr JW, Vitetta ES. 1984. Increased expression of Ia antigens on resting B cells: an additional role for B-cell growth factor. Proc. Natl. Acad. Sci. USA 81:6149-53
19. Defrance T, Aubry JP, Rousset F, Vanbervliet B, Bonnefoy JY, Arai N, Takebe Y, Yokota T, Lee F, Arai K, et al. 1987. Human recombinant interleukin 4 induces Fe epsilon receptors (CD23) on normal human B lymphocytes. J. Exp. Med. 165:1459-67
20. Ohara J, Paul WE. 1988. Up-regulation of interleukin 4/B-cell stimulatory factor 1 receptor expression. Proc. Natl. Acad. Sci. USA 85:8221-25
21. Snapper CM, Hornbeck PV, Atasoy U, Pereira GM, Paul WE. 1988. Interleukin 4 induces membrane Thy-1 expression on normal murine B cells. Proc: Natl. Acad. Sci. USA 85:6107-11
22. Howard M, Farrar J, Hilfiker M, Johnson B, Takatsu K, Hamaoka T, Paul WE. 1982. Identification of a T cell-derived B cell growth factor distinct from interleukin 2. J. Exp. Med. 155:914-23
23. Hu-Li J, Shevach EM, Mizuguchi J, Ohara J, Mosmann T, Paul WE. 1987. B cell stimulatory factor 1 (interleukin 4) is a potent costimulant for normal resting T lymphocytes. J. Exp. Med. 165:157-72
24. Dancescu M, Rubio-Trujillo M, Biron G, Bron D, Delespesse G, Sarfati M. 1992. Interleukin 4 protects chronic lymphocytic leukemie B cells from death by apoptosis and upregulates Bcl-2 expression. J. Exp. Med. 176:1319-26
25. Illera VA, Perandones CE, Stunz LL, Mower J, Ir DA, Ashman RF. 1993. Apoptosis in splenic B lymphocytes: regulation by protein kinase C and IL-4. J. Immunol. 151:2965-73
26. Zamorano J, Wang HY, Wang LM, Pierce JH, Keegan AD. 1996. IL-4 protects cells From apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J. Immunol. 157:4926-34
27. Boise LH, Minn AJ, June CH, Lindsten T, Thompson CB. 1995. Growth factors can enhance lymphocyte survival without committing the cell to undergo cell division. Proc. Natl. Acad. Sci. USA 92:5491-95
28. Minshall C, Arkins S, Straza J, Conners J, Dantze R, Freund GG, Kelley KW. 1997. IL-4 and insulin-like growth factor-I inhibit the decline in Bcl-2 and promote the survival of IL-3-deprived myeloid progenitors. J. Immunol. 159:1225-32
29. Thornhill MH, Wellicoms SM, Mahiouz DL, Lanchbury JS, Kyan-Aung U, Haskard DO. 1991. Tumor necrosis factor combines with IL-4 or IFNgamma to selectively enhance endothelial cell adhesiveness for T cells. The contribution of vascular cell adhesion molecule-1-dependent and -independent binding mechanisms. J. Immunol. 146:592-98
30. Bennett BL, Cruz R, Lacson RG, Manning AM. 1997. Interleukin-4 suppression of tumor necrosis factor alpha-stimulated E-selectin gene transcription is mediated by STAT-6 antagonism of NF-kappaB. J. Biol. Chem. 272:10212-19
31. Ohara J, Paul WE. 1987. Receptors for B-cell stimulatory factor-1 expressed on cells of haematopoietic lineage. Nature 325:537-40
32. Lowenthal JW, Castle BE, Christiansen J, Schreurs J, Rennick D, Arai N, Hoy P, Takebe Y, Howard M. 1988. Expression of high affinity receptors for murine interleukin 4 (BSF-1) on hemopoietic and non-hemopoietic cells. J. Immunol. 140:456-64
33. Lai SY, Molden J, Liu KD, Puck JM, White MD, Goldsmith MA. 1996. Interleukin-4-specific signal transduction events are driven by homotypic interactions of the interleukin-4 receptor alpha subunit. EMBO J. 15:4506-14
34. Fujiwara H, Hanissian SH, Tsytsykova A, Geha RS. 1997. Homodimerization of the human interleukin 4 receptor alpha chain induces Cepsilon germline transcripts in B cells in the absence of the interleukin 2 receptor gamma chain. Proc. Natl. Acad. Sci. USA 94:5866-71
35. Reichel M, Nelson BH, Greenberg PD, Rothman PB, Lu B, Reichel M, Fisher DA, Smith JF, Rothman P. 1997. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT-6 and the induction of IL-4-specific gene expression. J. Immunol. 158:5860-67
36. Russell SM, Keegan AD, Harada N, Nakamura Y, Noguchi M, Leland P, Friedmann MC, Miyajima A, Puri RK, Paul WE, et al. 1993. Interleukin-2 receptor gamma chain: a functional component of the interleukin-4 receptor. Science 262:1880-3
37. Leonard WJ, Noguchi M, Russell SM. 1994. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID). Adv. Exp. Med. Biol. 365:225-32
38. Kondo M, Takeshita T, Ishii N, Nakamura M, Watanabe S, Arai K, Sugamura K. 1993. Sharing of the interleukin-2 (IL-2) receptor gamma chain between receptors for IL-2 and IL-4. Science 262:1874-77
39. Letzelter F, Wang Y, Sebald W. 1998. The interleukin-4 site-2 epitope determining binding of the common receptor gamma chain. Eur. J. Biochem. 257:11-20
40. Obiri NI, Debinski W, Leonard WJ, Puri RK. 1995. Receptor for interleukin 13. Interaction with interlcukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15. J. Biol. Chem. 270:8797-8804
41. Obiri NI, Leland P, Murata T, Debinski W, Puri RK. 1997. The IL-13 receptor structure differs on various cell types and may share more than one component with IL-4 receptor. J. Immunol. 158:756-64
42. Miloux B, Laurent P, Bonnin O, Lupker J, Caput D, Vita N, Ferrara P. 1997. Cloning of the human IL-13R alpha1 chain and reconstitution with the TL4R alpha of a functional IL-4/IL-13 receptor complex. FEBS Lett. 401:163-66
43. Murata T, Taguchi J, Puri RK. 1998. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors. Blood 91:3884-91
44. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA. 1996. Cloning and characterization of a hinding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 93:497-501
45. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. 1996. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J. Biol. Chem. 271:29265-70
46. Dawson CH, Brown BL, Dobson PR. 1997. A 70-kDa protein facilitates interleukin-4 signal transduction in the absence of the common gamma receptor chain. Biochem. Biophys. Res. Commun. 233:279-82
47. Miyajima A, Kitamura T, Harada N, Yokota T, Arai K. 1992. Cytokine receptors and signal transduction. Annu. Rev. Immunol. 10:295-331
48. Livnah O, Stura EA, Johnson DL, Middleton SA, Mulcahy LS, Wrighton NC, Dower WJ, Jolliffe LK, Wilson IA. 1996. Functional mimicry of a protein hormone by a peptide agonist: the EPO receptor complex at 2.8 A [see comments]. Science. 273:464-71
49. Mitsuyasu H, Izuhara K, Mao X-Q, Gao P-S, Arinobu Y, Enomoto T, Kawai M, Sasaki S, Dake Y, Hamasaki N, Shirakawa T, Hopkin JM. 1998. lIe50Val variant of IL-4 Ralpha upregulates IgE synthesis and associates with atopic asthma. Nature Med. 19:119-20
50. Mosley B, Beckmann MP, March CJ, Idzerda RL, Gimpel SD, VandenBos T, Friend D, Alpert A, Anderson D, Jackson J, et al. 1989. The murine interleukin-4 receptor: molecular cloning and characterization of secreted and membrane bound forms. Cell 59:335-48
51. Murakami M, Narazaki M, Hibi M, Yawata H, Yasukawa K, Hamaguchi M, TagaT, Kishimoto T. 1991. Critical cytoplasmic region of the interleukin 6 signal transducer gp130 is conserved in the cytokine receptor family. Proc: Natl. Acad. Sci. USA 88:11349-53
52. Minami Y, Kono T, Yamada K, Kobayashi N, Kawahara A, Perlmutter RM, Taniguchi T. 1993. Association of p56(lck) with IL-2 receptor beta chain is critical for the IL-2 induced activation of p56(lck). EMBO J. 12:759-68
53. de Vos AM, Ultsch M, Kossiakoff AA. 1992. Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255: 306-12
54. Cunningham BC, Ultsch M, De Vos AM, Mullerrin MG, Clauser KR, Wells JA. 1991. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule. Science 254:821-25
55. Kammer W, Lischke A, Moriggl R, Groner B, Ziemiecki A, Gurniak CB, Berg LJ, Friedrich K. 1996. Homodimerization of interleukin-4 receptor alpha chain can induce intracellular signaling. J. Biol. Chem. 271:23634-37
56. Ihle JN. 1995. The Janus protein tyrosine kinase family and its role in cytokine signaling. Adv. Immunol. 60:1-35
57. Taniguchi T. 1995. Cytokine signaling through nonreceptor protein tyrosine kinases. Science 268:251-55
58. Witthuhn BA, Silvennoinen O, Miura O, Lai KS, Cwik C, Liu ET, Ihle JN. 1994. Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cells. Nature 370:153-57
59. Johnston JA, Kawamura M, Kirken RA, Chen Y-Q, Blake, TB, Shibuya K, Ortaldo R, McVicar DW, O'Shea JJ. 1994. Phosphorylation and activation of the Jak-3 kinase in response to interleukin-2. Nature 370:151-53
60. Murata T, Noguchi PD, Puri RK. 1996. IL-13 induces phosphorylation and activation of JAK2 Janus kinase in human colon carcinoma cell lines: similarities between IL-4 and IL-13 signaling. J. Immunol. 156:2972-78
61. Miyazaki T, Kawahara A, Fujii H, Nakagawa Y, Minami Y, Liu Zj, Oishi I, Silvennoinen O, Witthahn BA, Ihle JN, et al. 1994. Functional activation of Jak1 and Jak3 by selective association with IL-2 receptor subunits. Science 266:1045-47
62. Russell SM, Johnston JA, Noguchi M, Kawamura M, Bacon CM, Friedmann M, Berg M, McVicar DW, Witthuhn BA, Silvennoinen O, et al. 1994. Interaction of IL-2R beta and gamma-c chains with Jak1 and Jak3; implications for XSCID and XCID. Science 266:1042-45
63. Deutsch HH, Koettnitz K, Chung J, Kalthoff FS. 1995. Distinct sequence motifs within the cytoplasmic domain of the human IL-4 receptor differentially regulate apoptosis inhibition and cell growth. J. Immunol. 154:3696-3703
64. Izuhara K, Feldman RA, Greer P, Harada N. 1994. Interaction of the c-fes proto-oncogene product with the interleukin-4 receptor. J. Biol. Chem. 269:18623-29
65. Smerzbertling C, Duschl A. 1995. Both interleukin-4 and interleukin-13 induce tyrosine phosphorylation of the 140 kD subunit of the interleukin-4 receptor. J. Biol. Chem. 270:966-70
66. Galizzi JP, Zuber CE, Harada N, Gorman DM, Djossou O, Kastelein R, Banchereau J, Howard M, Miyajima A. 1990. Molecular cloning of a cDNA encoding the human interleukin 4 receptor. Int. Immunol. 2:669-75
67. Keegan AD, Nelms K, White M, Wang LM, Pierce JH, Paul WE. 1994. An IL-4 receptor region containing an insulin receptor motif is important for IL-4 mediated IRS-I phosphorylation and cell growth. Cell 76:811-20
68. Koettnitz, Kalthoff FS. 1993. Human interleukin-4 receptor signaling requires sequences contained within two cytoplasmic regions. Eur. J. Immunol. 23:988-91
69. Seldin DC, Leder P. 1994. Mutational analysis of a critical signaling domain of the human interleukin 4 receptor. Proc. Natl. Acad. Sci. USA 91:2140-44
70. Ryan JJ, McReynolds LJ, Keegan A, Wang LH, Garfein E, Rothman P, Nelms K, Paul WE. 1996. Growth and gene expression are predominantly controlled by distinct regions of the human IL-4 receptor. Immunity 4:123-32
71. Wang L-M, Keegan AD, Paul WE, Heidaran MA, Gutkind JA, Pierce JH. 1992. IL-4 activates a distinct signal transduction cascade from IL-3 in factor-dependent myeloid cells. EMRO J. 11:4899-4908
72. Wang LM, Keegan AD, Li W, Lienhard GE, Pacini S, Gutkind JS, Myers MG, Sun XJ, White MF, Aaronson SA, et al. 1993. Common elements in interleukin-4 and insulin signaling pathways in factor-dependent hematopoietic cells. Proc. Natl. Acad. Sci. USA 90: 4032-36
73. Wang LM, Myers MG Jr, Sun XJ, Aaronson SA, White M, Pierce JH. 1993. IRS-1: essential for insulin-and IL-4-stimulated mitogenesis in hematopoietic cells, Science 261:1591-94
74. Sun XJ, Wang LM, Zhang Y, Yenush L, Myers MGJ, Glasheen E, Lane WS, Pierce JH, White MF. 1995. Role of IRS-2 in insulin and cytokine signalling. Nature 377:173-77
75. Wang HY, Paul WE, Keegan AD. 1996. IL-4 function can be transferred to the IL-2 receptor by tyrosine containing sequences found in the IL-4 receptor alpha chain. Immunity 4:113-21
76. While ME, Livingston JN, Backer JM, Lauris V, Dull TJ, Ullrich A, Kahn CR. 1988. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 54:641-49
77. Gustafson TA, He W, Craparo A, Schaub CD, O'Neill TJ. 1995. Phosphotyrosine-dependent interaction of SHC and insulin receptor substrate 1 with the NPEY motif of the insulin receptor via a novel non-SH2 domain. Mol. Cell. Biol. 15:2500-8
78. O'Neill TJ, Craparo A, Gustafson TA. 1994. Characterization of an interaction between insulin receptor substrate 1 and the insulin receptor by using the two-hybrid system. Mol. Cell. Biol. 14:6433-42
79. Kavanaugh WM, Williams LT. 1994. An alternative to SH2 domains for binding to tyrosing phosphorylated proteins. Science 266:1862-65
80. Zhou M-M, Ravichandran KS, Olejniczak ET, Petros AM, Meadows RP, Harlan JE, Wade WS, Burakoff SJ, Fesik SW. 1995. Structure and ligand recognition of the phosphotyrosine binding domain of She. Nature 92:7784-88
81. Eck MJ, Dhe-Paganon S, Trub T, Nolte RT, Shoelson SE. 1996. Structure of the IRS-1 PTB domain bound to the juxtamembrane region of the insulin receptor. Cell 85:695-705
82. Zhou MM, Huang B, Olcjniczak ET, Meadows RP, Shuker SB, Miyazaki M, Trub T, Shoelson SE, Fesik SW. 1996. Structural basis for IL-4 receptor phosphopeptide recognition by the IRS-1 PTB domain. Nat. Struct. Biol. 3:388-93
83. Trub T, Choi WE, Wolf G, Ottinger E, Chen Y, Weiss M, Shoelson SE. 1995. Specificity of the PTB domain of She for beta turn-forming pentapeptide motifs amino-terminal to phosphotyrosine. J. Biol. Chem. 270:18205-8
84. Wolf G, Trub T, Ottinger E, Groninga L, Lynch A, White M, Miyazaki M, Lee J, Shoelson SE. 1995. The PTB domains of IRS-1 and She have distinct but overlapping binding specificities. J Biol. Chem. 270:27407-10
85. Wang HY, Zamorano J, Keegan AD. 1998. A role for the insulin-interleukin-4 receptor motif of the IL-4 receptor alpha-chain in regulating activation of the insulin receptor substrate-2 and signal transducer and activator or transcription 6 pathways. Analysis by mutagenesis. J. Biol. Chem. 273:9898-9905
86. Lemmon MA, Ferguson KM, Sigler PB, Schlessinger J. 1995. Specific and high-affinity binding of inositol phosphates to an isolated pleckstrin homology domain. Proc. Natl. Acad. Sci. USA 92:10472-76
87. Yin Tu, Keller SR, Quelle FW, Witthuhn BA, Tsang MLS, Lienhard GE, IhIe JN, Yang YC. 1995. Interleukin-9 induces tyrosine phosphorylation of insulin-receptor substrate-1 via Jak tyrosine kinases. J. Biol. Chem. 270:20497-502
88. Johnston JA, Wang LM, Hanson EP, Sun XJ, White MF, Oakes SA, Pierce JH, O'Shea JJ. 1995. Interleukins 2, 4, 7, and 15 stimulate tyrosine phosphorylation of insulin receptor substrates 1 and 2 in T cells. Potential role of JAK kinases. J. Biol. Chem. 270:28527-30
89. Wang HY, Zamorano J, Yoerkie JL, Paul WE, Keegan AD. 1997. The IL-4-induccd tyrosine phosphorylation of the insulin receptor substrate is dependent on JAK1 expression in human fibrosarcoma cells. J. Immunol. 158:1037-40
90. Chen XH, Patel BK, Wang LM, Frankel M, Ellmore N, Flavell RA, LaRochelle WJ, Pierce JH. 1997. Jak1 expression is required for mediating interleukin-4-induced tyrosine phosphorylation of insulin receptor substrate and Stat-6 signaling molecules. J. Biol. Chem. 272: 6556-60
91. Burfoot MS, Rogers NC, Watling D, Smith JM, Pons S, Paonessaw G, Pellegrini S, White MF, Kerr IM. 1997. Janus kinase-dependent activation of insulin receptor substrate 1 in response to interleukin-4, oncostatin M, and the interferons. J. Biol. Chem. 272:24183-90
92. Sun XJ, Rothenberg P, Kahn CR, Backer JM, Araki E, Wilden PA, Cahill DA, Goldstein BJ, White MF. 1991. Structure of the insulin receptor substrate IRS-I defines a unique signal transduction protein. Nature 352:73-77
93. Sun XJ, Crimmins DL, Myers MG, Miralpeix M, White MF. 1993. Pleiotropic insulin signals are engaged by multisite phosphory lation of IKS-1. Mol. Cell. Biol. 13:7418-28
94. Kapeller R, Cantley LC. 1994. Phosphatidylinositol 3-kinase. Bioessays 16:565-76
95. Kapeller R, Prasad KV, Janssen O, Hou W, Schaffhausen BS, Rudd CE, Cantley LC. 1994. Identification of two SH3-binding motifs in the regulatory subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 269:1927-33
96. Klippel A, Escobedo JA, Hu Q, Williams LT. 1993. A region of the 85-kilodalton (kDa) subunit of phosphatidylinositol 3-kinase binds the 110-kDa catalytic subunit in vivo. Mol. Cell. Biol. 13:5560-66
97. Dhand R, Hara K, Hiles I, Bax B, Gout I, Panayotou G, Fry MJ, Yonezawa K, Kasuga M, Waterfield MD. 1994. P1 3-kinase: structural and functional analysis of intersubunit interactions. EMBO J. 13:511-21
98. Dhand R, Hiles I, Panayotou G, Roche S, Fry MJ, Gout I, Totty NF, Truong O, Vicendo P, Yonezawa K, et al. 1994. PI 3-kinase is a dual specificity enzyme: autoregulation by an intrinsic protein-serine kinase activity. EMBO J. 13:522-33
99. Izuhara K, Feldman RA, Greer P, Harada N. 1996. Interleukin-4 induces association of the c-fes proto-oncogene product with phosphatidylinositol-3 kinase. Blood 88:3910-18
100. Stephens LR, Jackson TR, Hawkins PT. 1993. Agonist-stimulated synthesis of phosphatidylinositol(3,4,5)-trisphosphate: a new intracellular signalling system? Biochem. Biophys. Acta 1179:27-75
101. Toker A, Cantley LC. 1997. Signalling through the lipid products of phosphoinositide-3-OH kinase. Nature 387:673-76
102. Auger KK, Serunian LA, Soltoff SP, Libby P, Cantley LC. 1989. PDGF-dependent tyrosine phosphorylation stimulates production of novel polyphosphoinositides in intact cells. Cell 57:167-75
103. Franke TF, Kaplan DR, Cantley LC, Toker A. 1997. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 275:665-68
104. Franke TF, Kaplan DR, Cantley LC. 1997. P13K: downstream AKTion blocks apoptosis. Cell 88:435-37
105. Lam K, Carpenter CL, Ruderman NB, Friel JC, Kelly KL. 1994. The phosphatidylinositol 3-kinase serine kinase phosphorylates IRS-1. Stimulation by insulin and inhibition by Wortmannin. J. Biol. Chem. 269:20648-52
106. Paz K, Hemi R, LeRoith D, Karasik A, Elhanany E, Kanety H, Zick Y. 1997. A molecular basis for insulin resistance. Elevated serine/threonine phosphorylation of IRS-1 and IRS-2 inhibits their hinding to the juxtamembrane region of the insulin receptor and impairs their ability to undergo insulin-induced tyrosine phosphorylation. J. Biol. Chem. 272:29911-18
107. Duronio V, Welham MJ, Abraham S, Dryden P, Schrader JW. 1992. p21ras activation via hemopoietin receptors and c-kit requires tyrosine kinase activity but not tyrosine phosphorylation of p21ras GTPase-activating protein. Proc. Natl. Acad. Sci. USA 89:1587-91
108. Welham MJ, Duronio V, Leslie KB, Bowtell D, Schrader JW. 1994. Multiple hemopoietins, with the exception of interleukin-4, induce modification of She and mSos1, but not their translocation. J. Biol. Chem. 269:21165-76
109. Chardin P, Camonis JH, Gale NW, van Aelst L, Schlessinger J, Wigler MH, BarSagi D. 1993. Human Sosf: a guanine nucleotide exchange factor for Ras that binds to GRB2. Science 260:133-43
110. Downward J. 1996. Control of ras activation. Cancer Surv. 27:87-100
111. Denhardt DT. 1996. Signal-transducing protein phosphorylation cascades mediated by Ras/Rho proteins in the mammalian cell: the potential for multiplex signalling. Bochem. J. 318:729-47
112. Marais R, Marshall CJ. 1996. Control of the ERK MAP kinase cascade by Ras and Raf Cancer Surv. 27:101-25
113. Davis RJ. 1995. Transcriptional regulation by MAP kinases. Mol. Reprod. Dev. 42:459-67
114. Welham JM, Duriono V, Schrader JW. 1994. Interleukin-4 dependent proliferation dissociates p44 erk1, erk2, and p21 ras activation from cell growth. J. Biol. Chem. 269:5865-73
115. Welham MJ, Learmonth L, Bone H, Schrader JW. 1995. Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J. Biol. Chem. 270:12286-96
116. Pruett W, Yuan Y, Rose E, Batzger AG, Harada N, Sloknik EY. 1995. Association between GRB2/Sos and insulin receptor substrate 1 is not sufficient for activation of extracellular signal-regulated kinases by interleukin-4: implications for Ras activation by insulin. Mol. Cell. Biol. 15:1778-85
117. Wery S, Letourneur M, Bertoglio J, Pierre J. 1996. Interleukin-4 induces activation of mitogen-activaled protein kinase and phosphorylation of she in human keratinocytes. J. Biol. Chem. 271:8529-32
118. Crowley MT, Harmer SL, DeFranco AL. 1996, Activation-induced association of a 145-kDa tyrosine-phosphorylated protein with She and Syk in B lymphocytes and macrophages. J. Biol. Chem. 271:1145-52
119. Zamorano J, Keegan AD. 1998. Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the Stat-6-docking tyrosines, signal protection from apoptosis. J. Immunol. 161:859-67
120. Nelms K, Snow AL, Hu-Li J, Paul WE. 1998, FRIP, a hematopoietic cell-specific rasGAP interacting protein phosphorylated in response to cytokine stimulation. Immunity 9:13-24
121. Pawson T. 1995. Protein modules and signalling networks. Nature 373:573-80
122. Songyang Z, Shoelson SE, Chaudhuri M, Gish G, Pawson T, Haser WG, King F, Roberts T, Ratnofsky S, Lechleider RJ, et al. 1991. SH2 domains recognize specific phosphopeptidc sequences. Cell 72: 767-78
123. Rozakis-Adcock M, McGlade J, Mbamalu G, Pelicci G, Daly R, Li W, Batzer A, Thomas S, Brugge J, Pelicci PG, et al. 1992. Association of the She and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. Nature 360:689-92
124. Salcini AR, McGlade J, Pelicci G, Nicoletti I, Pawson T, Pelicci PG. 1994. Formation of She-Grb2 complexes is necessary to induce neoplastic transformation by overexpression of She proteins. Oncogene 9:2827-36
125. Ueno H, Sasaki K, Honda H, Nakamoto T, Yamagata T, Miyagawa K, Mitani K, Yazaki Y, Hirai H. 1998. c-Cbl is tyrosine-phosphorylated by interleukin-4 and enhances mitogenic and surival signals of interleukin-4 receptor by linking with the phosphatidylinositol 3′-kinase pathway. Blood 91:46-53
126. Fukazawa T, Reedquist KA, Trub T, Soltoff S, Panchamoorthy G, Druker B, Cantley L, Shoelson SE, Band H. 1995. The SH3 domain-binding T cell tyrosyl phosphoprotein p120. Demonstration of its identity with the c-cbl protooncogene product and in vivo complexes with Fyn, Grb2, and phosphatidylinositol 3-kinase. J. Biol. Chem. 270:19141-50
127. Panchamoorthy G, Fukazawa T, Miyake S, Soltoff S, Reedquist K, Druker B, Shoelson S, Cantley L, Band H. 1996. p 120cbl is a major substrate of tyrosine phosphorylation upon B cell antigen receptor stimulation and interacts in vivo with Fyn and Syk tyrosine kinases, Grb2 and She adaptors, and the p85 subunit of phosphatidylinositol 3-kinase. J. Biol. Chem. 271:3187-94
128. Lupher ML Jr, Reedquist KA, Miyake S, Langdon WY, Band H. 1996. A novel phosphotyrosine-binding domain in the N-terminal transforming region of Cbl interacts directly and selectively with ZAP-70 in T cells. J. Biol. Chem. 271:24063-68
129. Fukazawa T, Miyake S, Band V, Band H. 1996. Tyrosine phosphorylation of Cbl upon epidermal growth factor (EGF) stimulation and its association with EGF receptor and downstream signaling proteins. J. Biol. Chem. 271:14554-59
130. Lavan BE, Fantin VR, Chang ET, Lane WS, Keller SR, Lienard GE. 1997. A novel 160-kDa phosphotyrosine protein in insulin-treated embryonic kidney cells is a new member of the insulin receptor substrate family. J. Biol. Chem. 272: 21403-7
131. Lavan BE, Lane WS, Lienard GE. 1997. The 60-kD phosphotyrosine protein in insulin-treated adipocytes is new member of the insulin receptor substrate family. J. Biol. Chem. 272:11439-43
132. Darnell JE. 1997. STATs and gene regulation. Science 277:1630-35
133. Velazquez L, Fellous M, Stark GR, Pellegrini S. 1992. A protein tyrosine kinase in the interferon alpha/beta signaling pathway. Cell 70:313-22
134. Delphin S, Stavnezer J. 1995. Regulation of antibody class switching to IgE: characterization of an IL-4-responsive region in the immunoglohulin heavy-chain. Takeda K, Tanaka T, Shi W, Matsumoto M, Minami M, Kashiwamura S, germline epsilon promoter. Ann. NY Acad. Sci. 764:123-35
135. Nakanishi K, Yoshida N, Kishimoto T, Akira S. 1996. Essential role of Stat-6 in IL-4 signalling. Nature 380:627-30
136. Mikita T, Campbell D, Wu PG, Williamson K, Schindler U. 1996. Requirements for interleukin-4-induced gene expression and functional characterization of Stat-6. Mol. Cell. Biol. 16:5811-20
137. Schindler U, Wu P, Rothe M, Brasseur M, McKnight SL. 1995. Components of a Stat recognition code: evidence for two layers of molecular selectivity. Immunity 2:689-97
138. Ihle JN. 1996. STATs: signal transducers and activators of transcription. Cell 84:331-34
139. Richter G, Hein G, Blakenstein T, Diamantstein T. 1995. The rat interleukin 4 receptor coevolution of ligand and receptor. Cytokine 7:237-41
140. Ryan JJ, McReynolds LJ, Huang H, Nelms K, Paul WE. 1998. Characterization of a mobile Stat-6 motif in the human IL-4 receptor. J. Immunol. 161:1811-21
141. Kim J, Reeves R, Rothman P, Boothby M. 1995. The non-histone chromosomal protein HMG-I(Y) contributes to repression of the immunoglobulin heavy chain germ-line epsilon RNA promoter. Eur. J. Immunol 25:798-808
142. Wang D, Zamorano J, Keegan AD, Boothby M. 1997. HMG-I(Y) phosphorylation status as a nuclear target regulated through insulin receptor substrate-1 and the I4R motif of the interleukin-4 receptor. J. Biol. Chem. 272:25083-90
143. Muller M, Laxton C, Briscoc J, Schindler C, Improta T, Darnell JB Jr, Stark GR, Kerr IM. 1993. Complementation of a mutant cell line: central role of the 91 kDa polypcptide of ISGF3 in the interferon-alpha and -gamma signal transduction pathways. EMBO J. 12:4221-28
144. Patel BKR, Pierce JH, LaRochelle WJ. 1998. Regulation of interleukin 4-mediated signaling by naturally occurring dominant negative and attenuated forms of human Stat-6. Proc. Natl. Acad. Sci. USA 95:172-77
145. Schaefer TS, Sanders LK, Nathans D. 1995. Cooperative transcriptional activity of Jun and Stat3 beta, a short form of Stat3. Proc. Natl. Acad. Sci. USA 92: 9097-9101
146. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ. 1995. Stal1 depends on transcriptional synergy with Sp1. J. Biol. Chem. 270:30264-67
147. Delphin S, Stavnezer J. 1995. Characterization of an interleukin 4 (IL-4) responsive region in the immunoglobulin heavy chain germline epsilon promoter: regulation by NF-IL-4, a C/EBP family member and NF-kappa B/p50. J. Exp. Med. 181:181-92
148. Shen CH, Stavnezer J. 1998. Interaction of Stat-6 and NF-kappaB: direct association and synergistic activation of interleukin-4-induced transcription. Mol. Cell Biol 18:3395-3404
149. Wen Z, Zhong Z, Darnell JE, Jr. 1995. Maximal activation of transcription by Stat1 and Stat3 requires both tyrosine and serine phosphorylation. Cell 82:241-50
150. David M, Petricoin Er, Benjamin C, Pine R, Weber MJ, Larner AC. 1995. Requirement for MAP kinase (ERK2) activity in interferon alpha-and interferon beta-stimulated gene expression through STAT proteins. Science 269:1721-23
151. Zhang X, Blenis J, Li HC, Schindler C, Chen-Kiang S. 1995. Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science 267:1990-94
152. Urban JF Jr, Noben-Trauth N, Donaldson DD, Madden KB, Morris SC, Collins M, Finkelman FD. 1998. IL-13, IL-4Ralpha, and Stat-6 are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 8:255-64
153. Vella AT, Dow S, Potter TA, Kappler J, Marrack P. 1998. Cytokinc-induced survival of activated T cells in vitro and in vivo. Proc. Natl. Acad. Sci. USA 95:3810-15
154. Huang H, Paul WE. 1998. Impaired interleukin 4 signaling in T helper type 1 cells. J. Exp. Med. 187:1305-13
155. Kaplan MH, Daniel C, Schindler U, Grusby MJ. 1998. Stat proteins control lymphocyte proliferation by regulating p27(Kip1) expression. Mol. Cell. Biol. 18:1996-2003
156. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. 1997. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N. Engl. J. Med. 337:1720-25
157. Hou JZ, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL. 1994. An interleukin-4-induced transcription factor-IL-4 Stat. Science 265:1701-6
158. Scharenberg AM, Kinet JP. 1996. The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell 87:961-64
159. Haque SJ, Wu Q, Kammer W, Friedrich K, Smith JM, Kerr IM, Stark GR, Williams BRG. 1997. Receptor-associated onstitutive protein tyrosine phosphatase activity controls the kinase function of JAK1. Proc. Natl. Acad. Sci. USA 94:8563-68
160. D'Ambrosio D, Hippen KL, Minskoff SA, Mellrnan I, Pani G, Siminovitch KA, Cambier JC. 1995. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RIIB1. Science 268:293-97
161. Burshtyn DN, Scharenberg AM, Wagtmann N, Rajagopalan S, Berrada K, Yi T, Kinet JP, Long EO. 1996. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 4:77-85
162. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV. 1994. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RIIB modulates B-cell receptor signalling. Nature 369:340
163. Daeron M, Latour S, Malbec O, Espinosa E, Pina P, Pasmans S, Fridman WH. 1995. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RIIB, regulates negatively BCR-, TCR-, and FcR-depcndent cell activation. Immunity 3:635-46
164. Imani F, Rager KJ, Catipovic B, Marsh DG. 1997. Interleukin-4 induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J. Biol. Chem. 272:7927-31
165. Kuhne MR, Pawson T, Lienhard GE, Feng GS. 1993. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J. Biol. Chem. 16:11479-81
166. Gadina M, Stancato LM, Bacon CM, Larner AC, O'Shea JJ. 1998. Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role J. Immunol. 160:4657-61
167. Sun XJ, Pons S, Wang LM, Zhang Y, Yenush L, Burks D, Myers MG Jr, Glasheen E, Copeland NG, Jenkins NA, Pierce JH, White MF. 1997. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol. Endocrinol. 11:251-62
168. Hof P, Pluskey S, Dhe-Paganon S, Eck MJ, Shoelson SE. 1998. Crystal structure of the tyrosine phosphatase SHP-2. Cell 92:441-50
169. Shultz LD, Schweitzer PA, Rajan TV, Yi T, Ihle JN, Matthews RJ, Thomas MI., Beier DR. 1993. Mutations at the murine motheaten locus are within the hematopoietic cell protein-tyrosine phosphatase (Hcph) gene. Cell 73:1445-54
170. David M, Chen HE, Goelz S, Larner AC, Neel BG. 1995. Differential regulation of the alpha/beta interferon-stimulated Jak/Stat pathway by the SH2 domain-containing tyrosine phosphatase SHPTP1. Mol. Cell. Biol. 15:7050-58
171. D'Ambrosia D, Fong DC, Cambier JC. 1996. The SHIP phosphatase becomes associated with Fc gamma RIIB1 and is tyrosine phosphorylated during negative signaling. Immunol. Lett. 54:77-82
172. Damen JE, Liu L, Rosten P, Humphries RK, Jefferson AB, Majerus PW, Krystal G. 1996. The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphatidylinositol 3,4,5-triphosphale 5-phosphatase. Proc. Natl Acad. Sci. USA 93:1689-93
173. Ware MD, Rosten P, Damen JE, Liu L, Humphries RK, Krystal G. 1996. Cloning and characterization of human SHTP, the 145-kD inositol 5-phosphatase that associates with SHC after cytokine stimulation. Blood 88:2833-40
174. Starr R, Willson TA, Viney EM, Murray LJ, Rayner JR, Jenkins BJ, Gonda TJ, Alexander WS, Metcalf D, Nicola NA, Hilton DJ. 1997. A family of cytokine-inducible inhibitors of signalling. Nature 387:917-21
175. Naka T, Narazaki M, Hirata M, Matsumoto T, Minamoto S, Aono A, Nishimoto N, Kajita T, Taga T, Yoshizaki K, Akira S, Kishimoto T. 1997. Structure and function of a new STAT-induced STAT inhibitor. Nature 387:924-29
176. Endo TA, Masuhara M, Yokouchi M, Suzuki R, Sakamoto H, Mitsui K, Matsumoto A, Tanimura S, Ohtsubo M, Misawu H, Miyazaki T, Leonor N, Taniguchi T, Fujita T, Kanakura Y, Komiya S, Yoshimura A. 1997. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 387:921-24
177. Boguski MS, McCormick F. 1993. Proteins regulating Ras and its relatives. Nature 366:643-54
178. Trahey M, McCormick F. 1987. A cytoplasmic protein stimulates normal N-ras p21 GTPase, but does not affect oncogenic mutants. Science 238:542-45
179. Carpino N, Wisniewski D, Strife A, Marshak D, Kobayashi R, Stillman B, Clarkson B. 1997. p62(dok): a constitutively tyrosine-phosphorylated. GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 88:197-204
180. Yamanashi Y, Baltimore D. 1997. Identification of the Abl-and rasGAP associated 62 kDa protein as a docking protein, Dok. Cell 88:205-11
181. Di Cristofano A, Carpino N, Dunant N, Friedland G, Kobayashi R, Strife A, Wisniewski D, Clarkson B, Pandolti PP, Resh MD. 1998. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J. Biol. Chem. 273:4827-30
182. Meier H, Myers DD, Huebner RJ. 1963. Genetic control by the hr-locus of susceptibility and resistance to leukemia. Proc. Natl. Acad. Sci. 63:759-66
183. Boussiotis VA, Freeman GJ, Berezovskaya A, Barber DL, Nadler LM. 1997. Maintenance of human T cell anergy: blocking of IL-2 gene transcription by activated Rap1. Science 278:124-28